JP2016500250A5 - - Google Patents

Download PDF

Info

Publication number
JP2016500250A5
JP2016500250A5 JP2015543148A JP2015543148A JP2016500250A5 JP 2016500250 A5 JP2016500250 A5 JP 2016500250A5 JP 2015543148 A JP2015543148 A JP 2015543148A JP 2015543148 A JP2015543148 A JP 2015543148A JP 2016500250 A5 JP2016500250 A5 JP 2016500250A5
Authority
JP
Japan
Prior art keywords
amino acid
protein
modified protein
acid residues
reference secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2015543148A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016500250A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/071091 external-priority patent/WO2014081884A1/en
Publication of JP2016500250A publication Critical patent/JP2016500250A/ja
Publication of JP2016500250A5 publication Critical patent/JP2016500250A5/ja
Withdrawn legal-status Critical Current

Links

JP2015543148A 2012-11-20 2013-11-20 改変された分泌タンパク質及び方法 Withdrawn JP2016500250A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261728427P 2012-11-20 2012-11-20
US61/728,427 2012-11-20
PCT/US2013/071091 WO2014081884A1 (en) 2012-11-20 2013-11-20 Engineered secreted proteins and methods

Publications (2)

Publication Number Publication Date
JP2016500250A JP2016500250A (ja) 2016-01-12
JP2016500250A5 true JP2016500250A5 (enExample) 2017-01-19

Family

ID=50776536

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015543148A Withdrawn JP2016500250A (ja) 2012-11-20 2013-11-20 改変された分泌タンパク質及び方法

Country Status (7)

Country Link
US (1) US20150307562A1 (enExample)
EP (1) EP2922416A4 (enExample)
JP (1) JP2016500250A (enExample)
CN (1) CN104936466A (enExample)
CA (1) CA2892021A1 (enExample)
HK (1) HK1214739A1 (enExample)
WO (1) WO2014081884A1 (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015029580A2 (pt) * 2013-05-31 2017-09-19 Dsm Ip Assets Bv Microrganismo recombinante, processo para a preparação de um diterpeno ou diterpeno glicosilado, diterpeno ou diterpeno glicosilado, gêneros alimentícios, alimentos para animais ou bebidas e método para converter um primeiro diterpeno glicosilado em um segundo diterpeno glicosilado
CN105916981A (zh) 2013-07-29 2016-08-31 丹尼斯科美国公司 变体酶
EP3048904A2 (en) * 2013-09-25 2016-08-03 Pronutria Biosciences, Inc. Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
GB201401699D0 (en) * 2014-01-31 2014-03-19 Dupont Nutrition Biosci Aps Protein
CN103881994B (zh) * 2014-04-14 2020-03-27 中国农业科学院生物技术研究所 一种具有高转糖苷活性的β-半乳糖苷酶突变体及其制备方法和应用
FR3022558B1 (fr) 2014-06-20 2019-01-25 Proteus Variants d'exoglucanases a activite amelioree et leurs utilisations
ES2896401T3 (es) * 2014-09-22 2022-02-24 Tanea Medical Ab Proteínas recombinantes exentas de Phe para su uso en el tratamiento de la fenilcetonuria
CN107135653A (zh) * 2014-10-01 2017-09-05 安迅生物制药公司 大肠杆菌素变体
EP3217807A4 (en) * 2014-11-11 2018-09-12 Clara Foods Co. Methods and compositions for egg white protein production
DK3234143T5 (da) 2014-12-19 2024-10-14 Novozymes As Sammensætninger omfattende polypeptider med xylanaseaktivitet og polypeptider med arabinofuranosidaseaktivitet
GB201501565D0 (en) * 2015-01-30 2015-03-18 Dupont Nutrition Biosci Aps Method
WO2016149482A2 (en) * 2015-03-17 2016-09-22 Vanderbilt University Cs21 and lnga protein vaccines
DK3313193T3 (da) * 2015-06-26 2021-06-07 Novozymes As Fremgangsmåde til fremstilling af en kaffeekstrakt
US10188135B2 (en) * 2015-11-04 2019-01-29 Stokley-Van Camp, Inc. Method for inducing satiety
WO2017142080A1 (ja) 2016-02-18 2017-08-24 天野エンザイム株式会社 腸内菌叢改善剤
WO2017202997A1 (en) * 2016-05-24 2017-11-30 Novozymes A/S Compositions comprising polypeptides having galactanase activity and polypeptides having beta-galactosidase activity
EP3462904B1 (en) * 2016-05-24 2024-12-18 Novozymes A/S Gastric stable polypeptides having alpha-galactosidase activity and polynucleotides encoding same
WO2017202966A1 (en) 2016-05-24 2017-11-30 Novozymes A/S Polypeptides having alpha-galactosidase activity and polynucleotides encoding same
US11273455B2 (en) 2016-06-27 2022-03-15 Novozymes A/S Method of dewatering post fermentation fluids
DK3481948T5 (da) * 2016-07-08 2024-09-02 Novozymes As Xylanasevarianter og polynukleotider, der koder for dem
JP6845244B2 (ja) * 2016-07-19 2021-03-17 サントリーホールディングス株式会社 モグロールまたはモグロール配糖体の生産方法
PT3290436T (pt) 2016-09-01 2019-08-30 Metax Inst Fuer Diaetetik Gmbh Proteína livre de fenilalanina para o tratamento de pku
EA201891926A1 (ru) * 2017-02-03 2019-04-30 Киверди, Инк. Микроорганизмы и искусственные экосистемы для производства белка, продуктов питания и полезных побочных продуктов из субстратов c1
EP3592429A1 (en) * 2017-03-06 2020-01-15 DuPont Nutrition Biosciences ApS Novel fungal fucosidases and their use in preventing and/or treating a pathogenic infection in an animal
EP3840582A4 (en) * 2018-08-21 2022-08-03 Clara Foods Co. MODIFICATION OF PROTEIN GLYCOSYLATION IN MICROORGANISMS
EP3877519B1 (en) 2018-11-09 2026-03-11 Ginkgo Bioworks, Inc. Biosynthesis of mogrosides
MX2021011361A (es) * 2019-03-19 2021-10-13 Bayer Cropscience Lp Proteinas de fusion, bacterias recombinantes y fragmentos de exosporios para la salud de las plantas.
SI3997118T1 (sl) 2019-07-11 2025-06-30 Clara Foods Co. Sestavek napitka, ki obsega rekombinantni ovomukoidni protein
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof
US10927360B1 (en) 2019-08-07 2021-02-23 Clara Foods Co. Compositions comprising digestive enzymes
PY2055454A (es) 2019-09-16 2022-03-31 Novozymes As Polipéptidos que poseen actividad de beta-glucanasa y polinucleótidos que los codifican
EP3892290A1 (en) * 2020-04-08 2021-10-13 NUMAFERM GmbH Variants of hlya and uses thereof
US12612436B2 (en) 2020-03-18 2026-04-28 Numaferm Gmbh Variants of hlya and uses thereof
WO2021207679A1 (en) * 2020-04-10 2021-10-14 Liberty Biosecurity, Llc Polypeptide compositions and uses thereof
CA3198703A1 (en) * 2020-11-13 2022-05-19 Timothy GEISTLINGER Methods and compositions for producing recombinant components for use in food and other products
US20240117331A1 (en) * 2021-02-10 2024-04-11 Novozymes A/S Polypeptides having pectinase activity, polynucleotides encoding same, and uses thereof
MX2023011028A (es) * 2021-03-25 2023-09-27 Bio Cat Inc Mezclas de proteasas micoticas y usos de las mismas.
CN114015678A (zh) * 2021-09-30 2022-02-08 中南民族大学 一种球形赖氨酸芽孢杆菌C3-41来源的氨肽酶Amp0279及其重组菌株和应用
MX2021014268A (es) * 2021-11-19 2022-02-16 Univ Mexico Nac Autonoma Proteina optimizada que comprende los aminoacidos esenciales para la nutricion humana.
US20230281444A1 (en) * 2022-03-04 2023-09-07 Cella Farms Inc Computational system and algorithm for selecting nutritional microorganisms based on in silico protein quality determination
KR20250005200A (ko) 2022-04-20 2025-01-09 노보자임스 에이/에스 유리 지방산을 제조하는 방법
WO2023215798A1 (en) * 2022-05-04 2023-11-09 Locus Biosciences, Inc. Phage compositions for escherichia comprising crispr-cas systems and methods of use thereof
US20250311734A1 (en) 2022-05-14 2025-10-09 Novozymes A/S Compositions and Methods for Preventing, Treating, Suppressing and/or Eliminatting Phytopathogenic Infestations and Infections
CN115160420B (zh) * 2022-06-24 2023-06-02 西南大学 盔形毕赤酵母scp类分泌蛋白及其应用
WO2024220717A1 (en) * 2023-04-20 2024-10-24 Ginkgo Bioworks, Inc. Biosynthesis of mogrosides
WO2025155915A1 (en) * 2024-01-17 2025-07-24 Anagram Therapeutics, Inc. Methods and compositions for treating congenital sucrase-isomaltase deficiency

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800726B1 (en) * 1996-11-01 2004-10-05 Pioneer Hi-Bred International, Inc. Proteins with increased levels of essential amino acids
AR017831A1 (es) * 1997-12-10 2001-10-24 Pioneer Hi Bred Int Metodo para alterar la composicion de aminoacidos de una proteina nativa de interes, proteina elaborada, y polinucleotido
US20060159724A1 (en) * 2000-08-08 2006-07-20 Bell Stacey J Nutritional supplement for the management of weight
BR0212530A (pt) * 2001-09-17 2005-04-12 Monsanto Technology Llc Proteìnas reforçadas e métodos para seu uso
US7273738B2 (en) * 2002-10-01 2007-09-25 Novozymes A/S Family GH-61 polypeptides
CN1557475A (zh) * 2004-02-04 2004-12-29 高春平 美容、减肥营养组合物
EP2327316B1 (en) * 2009-11-29 2016-11-16 Premier Nutrition Corporation Method of enhancing muscle protein synthesis
CA2786001A1 (en) * 2009-12-31 2011-07-07 Pioneer Hi-Bred International, Inc. Engineering plant resistance to diseases caused by pathogens
WO2012128260A1 (ja) * 2011-03-24 2012-09-27 旭硝子株式会社 シゾサッカロミセス属酵母の形質転換体、該形質転換体の製造方法、β-グルコシダーゼの製造方法、およびセルロースの分解方法
WO2013148329A1 (en) * 2012-03-26 2013-10-03 Pronutria, Inc. Charged nutritive proteins and methods

Similar Documents

Publication Publication Date Title
HK1206764A1 (en) Nutritive proteins and methods
HK1214739A1 (zh) 工程化的分泌蛋白质和方法
JP2015513904A5 (enExample)
HK1206370A1 (en) Charged nutritive proteins and methods
NZ628126A (en) Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
JP2015501656A5 (enExample)
RU2019108268A (ru) Варианты химозина с улучшенными молокосвертывающими свойствами
IN2014CN00414A (enExample)
EA201190326A1 (ru) Полипептиды гормона роста и способы их получения и применения
RU2017104529A (ru) Композиции neisseria meningitidis и способы их применения
JP2015519878A5 (enExample)
RU2014143031A (ru) Фрагменты питательных белков и способы их применения
MX2024010472A (es) Polipeptidos que enlazan adamts5, mmp13 y agrecano.
MX2018016114A (es) Una novedosa fructosa-6-fosfato-3-epimerasa termoestable y un procedimiento para producir alulosa mediante el uso de la misma.
WO2013040093A3 (en) Glucagon-like peptide-2 compositions and methods of making and using same
JP2015212284A5 (enExample)
MX2011008094A (es) Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos.
JP2015518470A5 (enExample)
MX2012005864A (es) Proteinas de enlace al antígeno anti-orai 1 y usos de las mismas.
NZ612312A (en) Her2 binding peptides labeled with aluminium-[18] fluoride complexed by nota
HK1206763A1 (en) Charged nutritive fragments, proteins and methods
WO2010115995A3 (en) Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
JP2011125329A5 (enExample)
HK1206762A1 (en) Nutritive fragments and proteins with low or no phenylalanine and methods
MX2019000082A (es) Una novedosa tagatosa-6-fosfato fosfatasa termoestable y un procedimiento para producir tagatosa usando la misma.